BUTORPHANOL TARTRATE

Generic: BUTORPHANOL TARTRATE

Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
BUTORPHANOL TARTRATEActive Substance
2009-05-01Original Approval

BUTORPHANOL TARTRATE is FDA application ANDA078400, sponsored by HIKMA FARMACEUTICA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG HYPERSENSITIVITY
48 reports
2
DRUG INEFFECTIVE
46 reports
3
PRODUCT DOSE OMISSION ISSUE
38 reports
4
NAUSEA
25 reports
5
PRURITUS
18 reports
6
HEADACHE
17 reports
7
VOMITING
17 reports
8
PAIN
16 reports
9
PRODUCT QUALITY ISSUE
15 reports
10
ANXIETY
14 reports